NO882917L - Fusjonsproteiner og partikler. - Google Patents

Fusjonsproteiner og partikler.

Info

Publication number
NO882917L
NO882917L NO88882917A NO882917A NO882917L NO 882917 L NO882917 L NO 882917L NO 88882917 A NO88882917 A NO 88882917A NO 882917 A NO882917 A NO 882917A NO 882917 L NO882917 L NO 882917L
Authority
NO
Norway
Prior art keywords
particles
fusion proteins
fusion
proteins
Prior art date
Application number
NO88882917A
Other languages
English (en)
Other versions
NO882917D0 (no
NO177793B (no
NO177793C (no
Inventor
Alan John Kingsman
Susan Mary Kingsman
Sally Elizabeth Adams
Michael Henry Malim
Elizabeth-Jane Claire Mellor
Original Assignee
British Bio Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626148A external-priority patent/GB8626148D0/en
Priority claimed from GB878708531A external-priority patent/GB8708531D0/en
Priority claimed from US07/036,807 external-priority patent/US5041385A/en
Application filed by British Bio Technology filed Critical British Bio Technology
Publication of NO882917D0 publication Critical patent/NO882917D0/no
Publication of NO882917L publication Critical patent/NO882917L/no
Publication of NO177793B publication Critical patent/NO177793B/no
Publication of NO177793C publication Critical patent/NO177793C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO882917A 1986-11-01 1988-06-30 Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten NO177793C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868626148A GB8626148D0 (en) 1986-11-01 1986-11-01 Antigen presentation & purification system
GB878708531A GB8708531D0 (en) 1987-04-09 1987-04-09 Fusion proteins & particles
US07/036,807 US5041385A (en) 1986-11-01 1987-04-10 Vector expressing fusion proteins and particles
PCT/GB1987/000764 WO1988003563A1 (en) 1986-11-01 1987-10-28 Fusion proteins and particles

Publications (4)

Publication Number Publication Date
NO882917D0 NO882917D0 (no) 1988-06-30
NO882917L true NO882917L (no) 1988-08-29
NO177793B NO177793B (no) 1995-08-14
NO177793C NO177793C (no) 1995-11-22

Family

ID=27263194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882917A NO177793C (no) 1986-11-01 1988-06-30 Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten

Country Status (8)

Country Link
EP (1) EP0330661B1 (no)
JP (2) JP2708046B2 (no)
AU (1) AU606896B2 (no)
CA (1) CA1339263C (no)
DE (1) DE3788807T2 (no)
ES (1) ES2010231A6 (no)
NO (1) NO177793C (no)
WO (1) WO1988003563A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329671B1 (en) * 1986-11-01 1994-01-12 British Bio-Technology Limited Particulate hybrid hiv antigens
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5631154A (en) * 1988-06-10 1997-05-20 Therion Biologics, Incorporated Self assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
WO1990005787A1 (en) * 1988-11-23 1990-05-31 The Regents Of The University Of California Position-specific insertion vectors and method of using same
CA2016897A1 (en) * 1989-05-17 1990-11-17 John W. Wills Retrovirus-mediated secretion of recombinant products
EP0474868B1 (en) * 1989-05-30 1996-11-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
DK0431128T3 (da) * 1989-06-01 2004-06-28 Therion Biolog Corp Vektor, der koder for selvsamlende, defekte, ikke-selvopformerende viruspartikler
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9107631D0 (en) * 1991-04-10 1991-05-29 British Bio Technology Proteinaceous particles
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
FR2703996B1 (fr) * 1993-04-16 1995-07-21 Transgene Sa Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote.
ATE362990T1 (de) * 1999-06-30 2007-06-15 Evotec Ag Virusähnliche partikel, vorbereitung und verwendung in screening und funktionelle genomanwendung
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
DE60037263T2 (de) * 2000-12-29 2008-10-09 Evotec Ag Virus-ähnliche Partikel, ihre Herstellung und ihre Verwendung beim pharmazeutischen Screening und funktionelle Genomanwendungen
FI116198B (fi) 2001-07-16 2005-10-14 Valtion Teknillinen Polypeptidien immobilisointimenetelmä
LT5414B (lt) 2005-04-13 2007-04-25 Biotechnologijos Institutas Monokloninių antikūnų gavimo būdas, hibridomos, gautos šiuo būdu ir rekombinantinės chimerinės į virusus panašios dalelės su įterptais kitų baltymų fragmentais kaip imunogenai hibridomų gavimui šiuo būdu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
JPS6193199A (ja) * 1984-10-13 1986-05-12 Kyowa Hakko Kogyo Co Ltd 抗インタ−フエロン−γモノクロ−ナル抗体

Also Published As

Publication number Publication date
AU8105787A (en) 1988-06-01
JP2708046B2 (ja) 1998-02-04
ES2010231A6 (es) 1989-11-01
CA1339263C (en) 1997-08-12
NO882917D0 (no) 1988-06-30
DE3788807T2 (de) 1994-06-30
EP0330661A1 (en) 1989-09-06
JPH02501026A (ja) 1990-04-12
DE3788807D1 (de) 1994-02-24
JPH09248191A (ja) 1997-09-22
AU606896B2 (en) 1991-02-21
NO177793B (no) 1995-08-14
EP0330661B1 (en) 1994-01-12
NO177793C (no) 1995-11-22
WO1988003563A1 (en) 1988-05-19

Similar Documents

Publication Publication Date Title
DK568487A (da) Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse.
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
NO162422C (no) Kampolymerer samt fremstilling og anvendelse derav.
DK288184A (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK299087D0 (da) Proteins and derivatives thereof
NO882917L (no) Fusjonsproteiner og partikler.
NO881658D0 (no) Bifunksjonelle proteiner.
NO882226D0 (no) Fibrinolytiske proteiner.
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK224985A (da) Peptider, og midler indeholdende peptiderne
NO873216L (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
DK395288D0 (da) Proteiner
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK413187D0 (da) Semicarbazoner og thiosemicarbazoner
NO905561D0 (no) Proteiner og nukleinsyrer.
DK345087D0 (da) Protein
NO881502D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
IT8719698A0 (it) Metodo e dispositivo di fusione.
DK284489D0 (da) Fusionsproteiner
NO892948L (no) Modifiserte proteiner.
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
ATE100146T1 (de) Fusionsproteine und -partikel.
DK362088D0 (da) Fusionsproteiner og fusionsproteinpartikler
DK162089C (da) 1-phenoxy-3-hydroxyindolylalkylamino-2-propanoler og farmaceutiske praeparater indeholdende disse
NO881501D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003